Back to the top

Calls grow for fallopian tube removal to prevent ovarian cancer – The Boston Globe

Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women survive 5 years past their diagnosis, and 80 percent have no known risk factors. Now, a growing chorus of physicians is recommending a procedure that can significantly reduce the chances of developing ovarian cancer. The procedure is called a salpingectomy — or removal of the fallopian tubes, where the majority of ovarian cancer cases begin. The operation,......

Continue reading

Fallopian tube removal advised for more women to prevent ovarian cancer | Washington Post

In some cases, those who are done with childbearing may be advised to have tubes removed if they are having another gynecological surgery anyway By Teddy Amenabar, Amy Goldstein and Lindsey Bever To prevent more cases of ovarian cancer, a major research and advocacy group is suggesting an aggressive prevention strategy: remove a woman’s fallopian tubes if she is undergoing pelvic surgery for another reason. The practice would apply to women, trans men or nonbinary people at average risk who don’t plan to have any or additional children. The fallopian tubes are hollow structures that allow eggs to travel from......

Continue reading

Break Through Barriers To Drive Progress: Cancer Moonshot Pathways | Forbes

Published on August 8, 2022 at Forbes.com Written by Russell Flannery   MIT Professor Tyler Jacks has made a mark in cancer work not only by his research but his ability to bring different organizations together. Through his leadership, Break Through Cancer has spurred a first-of-its-kind collaboration of five of the top cancer research centers in the world: Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MIT’s Koch Institute for Integrative Cancer Research, The University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. The effort, funded with $250 million of help from......

Continue reading

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers Funding is part of $50 million in grants to teams at five cancer centers charged to work together  Contact: Clayton Boldt, Ph.D. Office: 713-792-9518 Cell: 409-673-5582 crboldt@mdanderson.org  HOUSTON ― The University of Texas MD Anderson Cancer Center...

Continue reading

Break Through Cancer Announces $50M in Grants to Empower Researchers from Five Top Cancer Research Centers to Work as One

New cancer research foundation will help accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers using a bold new approach. CAMBRIDGE, Mass., April 19, 2022 – Today, one year after its founding, Break Through Cancer announced $50 million in grants to support several cutting-edge research projects using a novel “TeamLab” structure—designed to maximize interdisciplinary collaboration among...

Continue reading

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH | The Cancer Letter

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH April 9, 2021 President Joe Biden April 9 announced his FY2022 budgetary plans for ARPA-H—Advanced Research Projects Agency-Health—a federal entity designed to “deliver breakthroughs to find cures for cancer and other diseases.” In his initial White House budget proposal—dubbed skinny budget, or budget-lite—Biden is requesting $6.5 billion to fund ARPA-H. “The discretionary request calls for $6.5 billion to launch the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health (NIH),” a White House press release states. “With an initial focus......

Continue reading

Cancer Matters with Dr Bill Nelson – Tyler Jacks from Break Through Cancer

Cancer Matters with Dr Bill Nelson – Tyler Jacks from Break Through Cancer April 1, 2021 Dr Bill Nelson speaks with Tyler Jacks, the President of Break Through Cancer, a collaborative partnership between The Johns Hopkins Kimmel Cancer Center, The Dana Farber Cancer Institute, The Koch Institute for Integrative Cancer Research at MIT, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center designed with the goal of curing the most lethal cancers. Listen Here...

Continue reading

Breaking Through Cancer: Collaborative translational research goes nationwide | Richmond Times-Dispatch

Breaking Through Cancer: Collaborative translational research goes nationwide March 16, 2021 The family of Richmond philanthropist William H. Goodwin Jr. has pledged $250 million toward the creation of a cancer foundation, which represents one of the largest gifts ever in cancer research. Read at Richmond Times-Dispatch...

Continue reading

Dana-Farber, MIT partner on $250M effort to cure most challenging cancers | Boston Business Journal

Dana-Farber, MIT partner on $250M effort to cure most challenging cancers | Boston Business Journal March 9, 2021 Two Massachusetts powerhouses in cancer research have joined together with three other partners to find treatments to some of the most challenging cancers, a pledge for which President Joe Biden has already signaled support. The Break Through Cancer foundation is supported by a $250 million pledge from Virginia real estate moguls Mr. and Mrs. William Goodwin Jr. and the estate of William Hunter Goodwin, III, their son who passed away of cancer in 2020. The gift is one of the largest ever......

Continue reading